{"id":13125,"date":"2019-04-29T07:48:32","date_gmt":"2019-04-29T11:48:32","guid":{"rendered":"https:\/\/medicarereport.org\/?p=13125"},"modified":"2019-04-29T07:48:32","modified_gmt":"2019-04-29T11:48:32","slug":"klobuchar-wants-to-stop-pay-for-delay-deals-that-keep-drug-prices-high","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=13125","title":{"rendered":"Klobuchar Wants To Stop \u2018Pay-For-Delay\u2019 Deals That Keep Drug Prices High"},"content":{"rendered":"

(By Emmarie Huetteman for Kaiser Health News)<\/p>\n

Washington\u2019s recent fixation with lowering drug costs has introduced Americans to once-insider terms like \u201cpharmacy benefit managers\u201d and \u201clist prices.\u201d<\/p>\n

During an April 22 CNN town hall event for Democratic candidates, Sen. Amy Klobuchar (D-Minn.) described a drugmaker practice that sounds a lot like bribery \u2014 drawing attention to yet another secretive process that lawmakers and experts say prevents patients from obtaining affordable prescription drugs.<\/p>\n

America, meet \u201cpay-for-delay.\u201d\u00a0 Continue reading article here…<\/a><\/p>\n

Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n

\"\"<\/a><\/p>\n

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n
 <\/p>\n","protected":false},"excerpt":{"rendered":"
(By Emmarie Huetteman for Kaiser Health News) Washington\u2019s recent fixation with lowering drug costs has introduced Americans to once-insider terms<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,21,15],"tags":[],"class_list":["post-13125","post","type-post","status-publish","format-standard","hentry","category-emerging-health-issues","category-health-care-finance","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13125","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=13125"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13125\/revisions"}],"predecessor-version":[{"id":13126,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/13125\/revisions\/13126"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=13125"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=13125"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=13125"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}